🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 7 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/08/2021 68,74 70,41 67,28 67,50 -2,23% 4,55% 597.800
03/08/2021 68,89 69,67 68,03 69,04 +0,66% 2,38% 613.100
02/08/2021 68,28 69,78 67,90 68,59 +1,20% 2,75% 521.500
30/07/2021 68,64 68,71 67,39 67,78 -1,70% 1,92% 642.700
29/07/2021 69,15 70,85 68,93 68,95 -0,16% 2,78% 631.600
28/07/2021 66,27 69,94 66,27 69,06 +4,26% 5,54% 823.900
27/07/2021 66,41 67,42 65,30 66,24 -0,51% 3,19% 678.700
26/07/2021 66,31 67,56 65,51 66,58 -0,31% 3,09% 411.400
23/07/2021 69,46 69,46 65,69 66,79 -3,36% 5,43% 659.600
22/07/2021 67,94 69,47 67,50 69,11 +0,95% 2,90% 799.600
21/07/2021 69,15 69,56 67,96 68,46 -1,17% 2,31% 747.200
20/07/2021 66,24 69,84 66,22 69,27 +5,00% 5,46% 1.047.800
19/07/2021 66,35 66,91 65,36 65,97 -1,61% 2,34% 920.800
16/07/2021 68,71 68,83 66,57 67,05 -1,93% 3,29% 830.200
15/07/2021 66,60 68,65 66,04 68,37 +2,27% 3,92% 1.183.400
14/07/2021 69,29 69,31 65,88 66,85 -3,51% 4,95% 1.245.000
13/07/2021 70,07 71,46 68,57 69,28 -1,99% 4,12% 936.400
12/07/2021 72,92 73,04 70,51 70,69 -3,23% 3,47% 594.000
09/07/2021 73,01 73,18 71,80 73,05 +0,15% 1,89% 303.300
08/07/2021 71,68 73,26 70,94 72,94 +1,32% 3,24% 455.700
07/07/2021 73,00 73,69 71,34 71,99 -1,69% 3,22% 728.300
06/07/2021 74,94 75,11 72,78 73,23 -2,67% 3,11% 758.500
02/07/2021 77,82 78,21 75,18 75,24 -3,87% 3,89% 655.500
01/07/2021 77,63 78,53 77,02 78,27 +0,68% 1,95% 629.400
30/06/2021 78,88 79,08 77,13 77,74 -1,37% 2,47% 730.500
29/06/2021 80,78 80,98 78,38 78,82 -2,43% 3,22% 792.800
28/06/2021 80,98 81,24 79,68 80,78 +0,47% 1,93% 462.900
25/06/2021 79,80 80,89 78,30 80,40 +0,90% 3,25% 1.231.000
24/06/2021 78,51 80,47 78,09 79,68 +1,68% 3,03% 631.300
23/06/2021 79,61 80,00 78,03 78,36 -1,56% 2,47% 578.300